The Stanford researchers developed a surgical strike to replace the nuke. They used an antibody called anti-CD117 to target ...
Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present ...
A Stanford study confirmed a complete reversal of type 1 diabetes in mice through a combination of stem cell transplants and ...
This is a preview. Log in through your library . Abstract Autoimmune type 1 diabetes (T1D) and other autoimmune diseases are associated with particular MHC haplotypes and expansion of autoreactive T ...
A team at Stanford Medicine has delivered something people with Type 1 diabetes have waited decades to hear: a cure in ...